Mili
Product Images NDC 50090-3962

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Mili (NDC 50090-3962). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500903962)

Packaging label for Mili by A-S Medication Solutions showing product NDC 50090-3962-0. The label indicates it contains estradiol tablets USP, 0.25 mg/0.035 mg strength, with 28 tablets per card. Storage instructions specify protecting from light and storing at 68 to 77 degrees Fahrenheit. The label includes lot and product number information.*

FDA Label Image

Figure 1 (Norgestimate Fig1)

An instructional diagram showing how to use the Mili™ (norgestimate and ethinyl estradiol) tablet pack. It depicts a hand peeling off a day label strip to place at the top of a 28-tablet blister card organized in four rows by week, with instructions to select the correct day to start. The tablets are color-coded with dark blue for weeks 1-3 and green for week 4.*

FDA Label Image

Figure 2 (Norgestimate Fig2)

An instructional diagram showing a four-week oral tablet dosing schedule for Mili. The schedule includes rows labeled Week 1, Week 2, Week 3, and Week 4 with corresponding circles indicating daily tablet intake from Sunday through Saturday. Weeks 1 to 3 are marked with dark blue tablets, while Week 4 is marked with green tablets. The diagram also displays the active ingredients norgestimate and ethinyl estradiol, and a dosage of 0.250 mg/0.035 mg.*

FDA Label Image

Figure 3 (Norgestimate Fig3)

An illustration showing a vertical scale of pregnancy frequency ranging from fewer than 1 to 85 or more pregnancies per 100 women per year. It categorizes birth control methods based on their effectiveness, listing implants, injections, intrauterine devices, sterilization as most effective; birth control pills, skin patch, vaginal ring with hormones as moderate; condoms and diaphragm as less effective; no sex during fertile days, spermicide, and withdrawal as even less effective; and no birth control as least effective.*

FDA Label Image

Blister Pack (Norgestimate Fig4)

Illustration diagram showing how to select and apply a day label strip onto a Mili oral contraceptive tablet blister pack. It demonstrates picking the correct day label from a strip labeled Monday through Sunday, then peeling and placing it on the blister pack. The pack is labeled for four weeks with circles indicating tablet positions in dark blue and green colors, and includes medication details such as active ingredients.*

FDA Label Image

Blister Pack (Norgestimate Fig5)

An illustrated dosing calendar for Mili, showing a 28-day oral tablet regimen divided into four weeks. The first three weeks contain dark blue pills, labeled with active ingredients norgestimate and ethinyl estradiol (0.250 mg/0.035 mg). The final week shows green pills. Days of the week are indicated along the top, guiding daily tablet administration.*

FDA Label Image

Chemical Structure (Norgestimate Str)

Chemical structure diagram showing the molecular formulas of Norgestimate and Ethinyl Estradiol, two active ingredients often used in combination hormonal medications, labeled accordingly.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.